Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 5 call positions ($140.0m notional), 5 put positions ($75.8m notional) – listed below, not included above.
Holdings, Q1 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH | $84.6m7.79% | Added +737.2k |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $76.4m7.04% | Added +329.5k |
| HORIZON THERAPEUTICS PUB L HZNP | $64.2m5.91% | Reduced -223.8k |
| GLAXOSMITHKLINE PLC SPONSORED ADR | $55.5m5.11% | Added +692.0k |
| UNITED THERAPEUTICS CORP DEL UTHR | $52.4m4.83% | Reduced -99.7k |
| ASTRAZENECA PLC SPONSORED ADR | $49.4m4.55% | Reduced -204.0k |
| ASCENDIS PHARMA A/S SPONSORED ADR | $49.0m4.51% | Added +13.5k |
| DANAHER CORPORATION DHR | $46.9m4.32% | Reduced -10.3k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $38.9m3.58% | Added +1.8m |
| R1 RCM INC RCM | $36.4m3.35% | Added +628.4k |
| AVANTOR INC AVTR | $33.7m3.10% | Reduced -130.2k |
| MASIMO CORP MASI | $30.4m2.80% | New |
| AMARIN CORP PLC SPONS ADR NEW | $29.5m2.72% | Reduced -1.6m |
| HCA HEALTHCARE INC HCA | $27.9m2.57% | Added +62.3k |
| ENVISTA HOLDINGS CORPORATION NVST | $27.7m2.55% | Reduced -279.9k |
| AMNEAL PHARMACEUTICALS INC AMRX | $22.9m2.11% | Reduced -949.1k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $21.7m2.00% | Added +44.0k |
| ARK ETF TR ARKG | $21.6m1.99% | Reduced -194.0k |
| FATE THERAPEUTICS INC FATE | $17.7m1.63% | Added +201.3k |
| BIOGEN INC BIIB | $16.4m1.51% | Added +45.0k |
| MCKESSON CORP MCK | $16.1m1.48% | Reduced -83.7k |
| ELEVANCE HEALTH INC ELV | $15.9m1.47% | Reduced -1.8k |
| DEXCOM INC DXCM | $14.5m1.34% | Added +22.0k |
| GUARDANT HEALTH INC GH | $14.1m1.30% | Added +112.9k |
| IQVIA HLDGS INC IQV | $13.8m1.27% | Added +35.0k |
| ILLUMINA INC ILMN | $13.5m1.25% | New |
| XENON PHARMACEUTICALS INC XENE | $12.5m1.15% | Added +200.5k |
| ICON PLC ICLR | $11.4m1.05% | Reduced -5.1k |
| CENTENE CORP DEL CNC | $10.0m0.92% | Reduced -105.4k |
| LABORATORY CORP AMER HLDGS COM NEW | $10.0m0.92% | Reduced -7.6k |
| LIQUIDIA CORPORATION LQDA | $9.9m0.91% | Reduced -70.4k |
| NANOSTRING TECHNOLOGIES INC NSTG | $9.8m0.90% | Added +15.0k |
| HEALTHEQUITY INC HQY | $9.7m0.89% | Reduced -189.2k |
| TARO PHARMACEUTICAL INDS LTD TARO | $9.5m0.88% | Added +39.1k |
| QIAGEN NV SHS NEW | $9.4m0.87% | Added +30.2k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $8.6m0.79% | Reduced -17.4k |
| ORTHO CLINICAL DIAGNOSTICS H OCDX | $8.3m0.76% | Reduced -441.1k |
| ARGENX SE ARGX | $7.3m0.67% | Added +1.6k |
| REPLIGEN CORP RGEN | $6.9m0.63% | Added +31.9k |
| SYNEOS HEALTH INC INCR | $6.6m0.61% | Reduced -4.2k |
| IONIS PHARMACEUTICALS INC IONS | $5.9m0.54% | Reduced -226.0k |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $4.6m0.43% | Added +37.0k |
| EXELIXIS INC EXEL | $4.6m0.42% | Reduced -332.5k |
| IRHYTHM TECHNOLOGIES INC IRTC | $4.3m0.39% | Reduced -46.1k |
| 908 DEVICES INC MASS | $4.1m0.38% | New |
| PUMA BIOTECHNOLOGY INC PBYI | $4.1m0.38% | Added +306.8k |
| GOSSAMER BIO INC GOSS | $3.3m0.30% | Added +334.8k |
| VIRIDIAN THERAPEUTICS INC VRDN | $2.9m0.27% | Reduced -38.8k |
| ANAPTYSBIO INC ANAB | $2.8m0.26% | Reduced -68.4k |
| RADIUS HEALTH INC RDUS | $2.7m0.25% | New |
| AADI BIOSCIENCE INC WHWK | $2.6m0.24% | New |
| AGILENT TECHNOLOGIES INC A | $2.5m0.23% | Reduced -176 |
| INTUITIVE SURGICAL INC ISRG | $2.5m0.23% | Reduced -1.7k |
| MERUS N V MRUS | $2.0m0.19% | Added +57.8k |
| KARUNA THERAPEUTICS INC COM | $2.0m0.19% | Unchanged |
| MERCK & CO INC MRK | $2.0m0.18% | Reduced -10.0k |
| PERKINELMER INC RVTY | $1.7m0.16% | Reduced -21.1k |
| AUTOLUS THERAPEUTICS PLC AUTL | $1.5m0.14% | Reduced -30.0k |
| MILESTONE PHARMACEUTICALS IN MIST | $944.8k0.09% | Unchanged |
| ENSIGN GROUP INC ENSG | $936.4k0.09% | Unchanged |
| HESKA CORP HSKA | $807.0k0.07% | Added +1.3k |
| KODIAK SCIENCES INC KOD | $704.1k0.06% | New |
| ASSEMBLY BIOSCIENCES INC COM | $576.8k0.05% | Reduced -30.0k |
| SPERO THERAPEUTICS INC SPRO | $518.9k0.05% | New |
| SONIDA SENIOR LIVING INC SNDA | $503.9k0.05% | Unchanged |
| AC IMMUNE SA ACIU | $498.4k0.05% | Reduced -28.8k |
| ADAPTIMMUNE THERAPEUTICS PLC ADAPY | $488.4k0.04% | Reduced -111.6k |
| SURGALIGN HOLDINGS INC RTIX | $478.9k0.04% | Reduced -344.9k |
| BIO-TECHNE CORP TECH | $459.9k0.04% | New |
| ELEDON PHARMACEUTICALS INC ELDN | $449.2k0.04% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $414.6k0.04% | Added +110.7k |
| CYCLERION THERAPEUTICS INC COM | $412.9k0.04% | Unchanged |
| AVROBIO INC COM | $389.9k0.04% | Reduced -9.6k |
| ORCHARD THERAPEUTICS PLC ORTX | $298.7k0.03% | Unchanged |
| GLYCOMIMETICS INC COM | $114.7k0.01% | Added +579 |
| CLOVIS ONCOLOGY INC CLVS | $60.6k0.01% | New |
Sold out since Q4 2021
| Security | Value then |
|---|---|
| HUMANA INC HUM | $12.7m27.4k shares |
| INTRA-CELLULAR THERAPIES INC ITCI | $12.1m231.8k shares |
| ARK ETF TR ARKK | $11.3m119.1k shares |
| MAGELLAN HEALTH INC MGLN | $9.9m104.7k shares |
| NATERA INC NTRA | $9.5m102.1k shares |
| ZOGENIX INC ZGNX | $9.0m551.0k shares |
| INSULET CORP PODD | $8.0m30.2k shares |
| CERNER CORP CERN | $7.2m77.5k shares |
| SI-BONE INC SIBN | $5.7m258.1k shares |
| NEVRO CORP NVRO | $5.4m66.1k shares |
| AURINIA PHARMACEUTICALS INC AUPH | $4.6m201.4k shares |
| MARAVAI LIFESCIENCES HLDGS I MRVI | $3.7m87.8k shares |
| LEXICON PHARMACEUTICALS INC LXRX | $3.1m797.7k shares |
| CUREVAC N V CVAC | $2.9m85.0k shares |
| GRITSTONE BIO INC GRTS | $2.2m170.1k shares |
| MIRATI THERAPEUTICS INC MRTX | $2.2m14.8k shares |
| SANOFI SNY | $1.9m38.7k shares |
| ESTABLISHMENT LABS HLDGS INC ESTA | $1.7m25.1k shares |
| MYOMO INC MYO | $1.0m150.0k shares |
| VOCERA COMMUNICATIONS INC VCRA | $970.7k15.0k shares |
| LOGICBIO THERAPEUTICS INC LOGC | $672.4k291.1k shares |
| BROOKDALE SR LIVING INC BKD | $408.4k79.1k shares |
| F-STAR THERAPEUTICS INC | $250.7k49.9k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| GLAXOSMITHKLINE PLC Call | $67.7m1.6m shares | Added |
| INVESCO QQQ TR QQQ · Put | $65.3m180.0k shares | Reduced |
| ASTRAZENECA PLC Call | $38.0m572.3k shares | Unchanged |
| BIOGEN INC BIIB · Call | $29.5m140.0k shares | New |
| ISHARES INC EWT · Put | $6.1m100.0k shares | New |
| MERCK & CO INC MRK · Call | $4.0m48.7k shares | Unchanged |
| PROGYNY INC PGNY · Put | $2.6m50.0k shares | Unchanged |
| KODIAK SCIENCES INC KOD · Put | $1.4m181.2k shares | New |
| TEVA PHARMACEUTICAL INDS LTD Call | $872.3k92.9k shares | Reduced |
| ISHARES TR IWO · Put | $434.8k1.7k shares | Reduced |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |